Cadila Healthcare informs about press release

03 Feb 2020 Evaluate

Cadila Healthcare has informed that the company has enclosed a copy of press release dated February 3, 2020 titled ‘Zydus receives approval from DCGI for Saroglitazar Magnesium for treatment of Type II Diabetes.’ The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

890.60 14.25 (1.63%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×